Is Sarepta Therapeutics Inc stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Sarepta Therapeutics Inc pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Tuesday 15th of March 2022 were paid $0.285 per share. Over the last 1 times between 2022 and 2022, Sarepta Therapeutics Inc has paid $0.285 with an average of $0.29 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Sarepta Therapeutics Inc 10 years ago, but if you had invested on Tuesday 10th of August 2021 when the price was $77.50, you would have made a profit of $32.46 per share or 41.88%
No, the average daily trading liquidity for Sarepta Therapeutics Inc is $424 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Sarepta Therapeutics Inc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. Sarepta Therapeutics Inc has a good net profit margin of 7.43% and should have high tolerances against inflation.
We have calculated the inflation risk for Sarepta Therapeutics Inc to be medium [0.55 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.